Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents ; volume:26 ; number:1 ; day:23 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Arthritis Research & Therapy ; 26, Heft 1 (23.10.2024), 1-10, 12.2024
- Urheber
-
Del Papa, Nicoletta
Cavalli, Silvia
Rindone, Andrea
Onida, Francesco
Saporiti, Giorgia
Minniti, Antonina
Pellico, Maria Rosa
Iannone, Claudia
Trignani, Giorgia
D’Angelo, Nicoletta
Sette, Manuel
Greco, Raffaella
Vitali, Claudio
Caporali, Roberto
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-024-03408-4
- URN
-
urn:nbn:de:101:1-2501112100259.190688547144
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Del Papa, Nicoletta
- Cavalli, Silvia
- Rindone, Andrea
- Onida, Francesco
- Saporiti, Giorgia
- Minniti, Antonina
- Pellico, Maria Rosa
- Iannone, Claudia
- Trignani, Giorgia
- D’Angelo, Nicoletta
- Sette, Manuel
- Greco, Raffaella
- Vitali, Claudio
- Caporali, Roberto
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Successful therapy with rituximab in three patients with probable neurosarcoidosis
Nocardiosis in glomerular disease patients with immunosuppressive therapy
Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis
Selective elimination of immunosuppressive T cells in patients with multiple myeloma
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Successful therapy with rituximab in three patients with probable neurosarcoidosis
Nocardiosis in glomerular disease patients with immunosuppressive therapy
Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis
Selective elimination of immunosuppressive T cells in patients with multiple myeloma
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Successful therapy with rituximab in three patients with probable neurosarcoidosis
Nocardiosis in glomerular disease patients with immunosuppressive therapy
Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis
Selective elimination of immunosuppressive T cells in patients with multiple myeloma
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate